R. Kent Jr. McGaughy - 03 May 2024 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 May 2024, 21:46:20 UTC
Prior SEC filing
26 Sep 2023
Next SEC filing
13 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John Bateman, as Chief Operating Officer of CPMG, Inc.

Key filing fact

R. Kent Jr. McGaughy filed Form 4 for PROCEPT BioRobotics Corp (PRCT) on 07 May 2024.

Key facts

  • This page summarizes R. Kent Jr. McGaughy's Form 4 filing for PROCEPT BioRobotics Corp (PRCT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 07 May 2024, 21:46.

Change

  • Previous filing in this sequence was filed on 26 Sep 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRCT transaction

Common Stock

Other

Transaction value
$0
Shares
-1,785,127
Change %
-39%
Price
$0.000000
Shares after
2,823,681
Date
03 May 2024
Ownership
By White Tailed Ptarmigan, LP
Footnotes
F1, F2
PRCT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
54,037
Date
03 May 2024
Ownership
By Kestrel Fund, L.P.
Footnotes
F1, F3
PRCT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
344,627
Date
03 May 2024
Ownership
By Mallard Fund, L.P.
Footnotes
F1, F3
PRCT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
553,592
Date
03 May 2024
Ownership
By Lagos Trust
Footnotes
F3, F4
PRCT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,523
Date
03 May 2024
Ownership
Direct
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

R. Kent Jr. McGaughy is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

CPMG, Inc. is the general partner and investment manager of each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P. and Mallard Fund, L.P. (collectively, the "CPMG Funds"). In such capacities, CPMG, Inc. may be deemed to have voting and investment control over the shares beneficially owned by the CPMG Funds. Antal Desai, a member of the Issuer's board of directors, and Kent McGaughy, Jr., each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds. Each of Mr. Desai and Mr. McGaughy, Jr. disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein. Antal Desai reports his beneficial ownership of these shares on a separate Form 4.

Footnote F2

On May 3, 2024, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 421,061 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13.

Footnote F3

Includes shares previously held indirectly through White Tailed Ptarmigan, LP, which were distributed on a pro rata basis, for no consideration, on May 3, 2024, in a transaction exempt from Section 16 under Rules 16a-9 and 16a-13.

Footnote F4

Mr. McGaughy, Jr. is a trustee of Lagos Trust. Mr. McGaughy, Jr. disclaims beneficial ownership of the shares beneficially owned by Lagos Trust except to the extent of any pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .